Chris Molloy | Chief Executive Officer
BioIndustry Association

Professor Chris Molloy is Chief Executive Officer of the UK BioIndustry Association (BIA), the trade association representing the UK's innovative life sciences and biotechnology sector. He leads the organisation's work with industry, investors and government to create the conditions for biotech companies to start, scale, stay and serve the world from the UK. Previously, Chris was the founding CEO of Medicines Discovery Catapult, where he spent a decade bringing together academia, industry, the NHS and investors to accelerate drug discovery and strengthen the UK's life sciences ecosystem. During the COVID-19 pandemic, he established and led the UK's Lighthouse Laboratories network and chaired the national consortium responsible for scaling up lateral flow test manufacturing. Originally trained as a biomedical scientist, Chris has more than 35 years' international experience spanning biopharma, biotechnology, diagnostics, digital health and healthcare innovation. He is a Trustee of the Institute of Cancer Research and an  Honorary Professor at the Universities of Manchester and Birmingham. He is independent chair of Pharos AI – a unique multi-NHS Trust cancer sample, data and AI brokerage, and has advised governments, investors and boards on innovation, growth and life sciences strategy.